Published in Viruses on July 07, 2015
Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest (2017) 0.89
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site. Cell Rep (2016) 0.83
Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model). Pathogens (2015) 0.78
Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments. Antimicrob Agents Chemother (2017) 0.78
Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells. J Virol (2016) 0.77
Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery. Interdiscip Perspect Infect Dis (2017) 0.75
Immune-Mediated Protection and Pathogenesis of Chikungunya Virus. J Immunol (2016) 0.75
Characterization of a Chikungunya virus strain isolated from banked patients' sera. Virol J (2016) 0.75
Identification of Functional Determinants in the Chikungunya Virus E2 Protein. PLoS Negl Trop Dis (2017) 0.75
Prolonged shedding of Chikungunya virus in semen and urine: A new perspective for diagnosis and implications for transmission. IDCases (2016) 0.75
Characterization of β-d-N(4)-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus. Antimicrob Agents Chemother (2017) 0.75
Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: in silico structural modeling, docking and molecular dynamic studies. Virusdisease (2017) 0.75
A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog (2007) 10.38
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol (2005) 7.80
Virus entry: open sesame. Cell (2006) 6.33
The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell (2001) 5.65
Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell (1983) 5.46
Clathrin-independent endocytosis of ubiquitinated cargos. Proc Natl Acad Sci U S A (2005) 5.37
pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A (1980) 5.21
Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16
Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis (2009) 4.72
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity (2007) 4.49
Reversal of obesity by targeted ablation of adipose tissue. Nat Med (2004) 4.23
Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol (2006) 4.16
Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature (2004) 4.02
Virus entry by endocytosis. Annu Rev Biochem (2010) 3.74
The integrins. Genome Biol (2007) 3.72
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol (1998) 3.51
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J Virol (1989) 3.09
Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold. Cell (2001) 2.96
Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol (1994) 2.92
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest (2010) 2.92
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature (2010) 2.90
The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des (2008) 2.87
Multiple adenovirus serotypes use alpha v integrins for infection. J Virol (1994) 2.86
Evolutionary relationships and systematics of the alphaviruses. J Virol (2001) 2.84
TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol (2005) 2.77
Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis (2011) 2.69
A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit. J Cell Biol (1998) 2.65
Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis (2006) 2.61
Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J Virol (1992) 2.60
Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology (2000) 2.59
Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis (2009) 2.54
Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One (2007) 2.47
Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J (1993) 2.36
Envelope structure of Semliki Forest virus reconstructed from cryo-electron micrographs. Nature (1986) 2.35
Structural changes of envelope proteins during alphavirus fusion. Nature (2010) 2.32
The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol (1999) 2.28
Dynamin 2 is required for phagocytosis in macrophages. J Exp Med (1999) 2.22
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A (2011) 2.12
Reemergence of chikungunya virus. J Virol (2014) 2.11
Entomologic and virologic investigation of Chikungunya, Singapore. Emerg Infect Dis (2009) 2.10
Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure (2006) 2.05
Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein. J Virol (1994) 2.00
Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J (1994) 1.99
Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta (2008) 1.96
Arrival of chikungunya virus in the new world: prospects for spread and impact on public health. PLoS Negl Trop Dis (2014) 1.95
Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog (2011) 1.95
Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J Cell Biol (2005) 1.88
Clinical burden of chikungunya virus infection. Lancet Infect Dis (2008) 1.87
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res (2013) 1.85
Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris) (2007) 1.83
Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy. Proc Natl Acad Sci U S A (1995) 1.81
4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J (2011) 1.77
The Role of histidine residues in low-pH-mediated viral membrane fusion. Structure (2006) 1.75
Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol (2010) 1.74
Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine (1986) 1.74
Integrin alpha(v)beta1 is an adenovirus coreceptor. J Virol (2001) 1.72
A structural and functional perspective of alphavirus replication and assembly. Future Microbiol (2009) 1.72
Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines (2012) 1.69
Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol (1999) 1.69
Mapping the structure and function of the E1 and E2 glycoproteins in alphaviruses. Structure (2006) 1.68
The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J Virol (2002) 1.62
Replication cycle of chikungunya: a re-emerging arbovirus. Virology (2009) 1.61
Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol (2010) 1.60
Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes. Nat Commun (2014) 1.59
Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol (2006) 1.57
The lipid class composition of Semliki forest virus and plasma membranes of the host cells. Virology (1971) 1.56
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol (2008) 1.48
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog (2013) 1.47
Chikungunya: Evolutionary history and recent epidemic spread. Antiviral Res (2015) 1.45
An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety. J Virol (2001) 1.45
Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus. Prog Neurobiol (2009) 1.44
Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion. J Virol (2000) 1.42
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis (2012) 1.42
Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb Perspect Biol (2014) 1.41
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One (2011) 1.37
Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int (1997) 1.36
Clathrin-coated pits: vive la différence? Traffic (2007) 1.31
Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Virology (2006) 1.31
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88. J Virol (2005) 1.30
Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg (2005) 1.30
Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol (2013) 1.29
Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur Biophys J (2007) 1.29
Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol (2013) 1.26
The lipidomes of vesicular stomatitis virus, semliki forest virus, and the host plasma membrane analyzed by quantitative shotgun mass spectrometry. J Virol (2009) 1.25
Role of conserved histidine residues in the low-pH dependence of the Semliki Forest virus fusion protein. J Virol (2009) 1.24
On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis (2008) 1.24
Guillain-Barré syndrome after chikungunya infection. Emerg Infect Dis (2009) 1.24
Multistep regulation of membrane insertion of the fusion peptide of Semliki Forest virus. J Virol (2004) 1.23
Structures and target recognition modes of PDZ domains: recurring themes and emerging pictures. Biochem J (2013) 1.23
Simultaneous detection and quantitation of Chikungunya, dengue and West Nile viruses by multiplex RT-PCR assays and dengue virus typing using high resolution melting. J Virol Methods (2009) 1.22
Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol (2002) 1.19
Guillain-Barré syndrome complicating a Chikungunya virus infection. Neurology (2007) 1.19
Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem (2008) 1.18